We are live on ! Find out more
Jennison Associates

Jennison Associates Portfolio holdings

AUM $145B
1-Year Est. Return 34.61%
 

Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.

This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+34.61%
3 Year Est. Return
+158.21%
5 Year Est. Return
+226.99%
10 Year Est. Return
+1,390.17%
AUM
$109B
AUM Growth
-$59.8M
Cap. Flow
-$1.71B
Cap. Flow %
-1.56%
Top 10 Hldgs %
21.39%
Holding
801
New
92
Increased
315
Reduced
305
Closed
72

Sector Composition

Rank Sector Weight
1 Healthcare 20.97%
2 Consumer Discretionary 16.01%
3 Technology 12.95%
4 Communication Services 12.43%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HT
201
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$100M 0.09%
3,914,603
+536,038
+16% +$13.9M
AMTD
202
DELISTED
TD Ameritrade Holding Corp
AMTD
$100M 0.09%
+2,720,666
New +$101M
CWEN icon
203
Clearway Energy Class C
CWEN
$4.79B
$99.3M 0.09%
4,535,329
-997,459
-18% -$25.1M
LH icon
204
Labcorp
LH
$25.2B
$99.1M 0.09%
+951,965
New +$99.1M
TVTX icon
205
Travere Therapeutics
TVTX
$5.17B
$98.4M 0.09%
2,967,503
-276,384
-9% -$7.57M
H icon
206
Hyatt Hotels
H
$17.5B
$97.6M 0.09%
1,721,716
-6,605
-0.4% -$384K
GIII icon
207
G-III Apparel Group
GIII
$1.54B
$97.4M 0.09%
1,384,999
+66,461
+5% +$4.07M
TPST icon
208
Tempest Therapeutics
TPST
$14.3M
$97.3M 0.09%
1,150
+268
+30% +$24.5M
POR icon
209
Portland General Electric
POR
$5.82B
$97M 0.09%
2,924,490
-509,556
-15% -$17.9M
HCA icon
210
HCA Healthcare
HCA
$90.6B
$96.9M 0.09%
1,068,463
+6,264
+0.6% +$502K
TDG icon
211
TransDigm Group
TDG
$70.7B
$96.4M 0.09%
428,881
+56,628
+15% +$12.7M
AMSG
212
DELISTED
Amsurg Corp
AMSG
$96.2M 0.09%
1,374,617
+119,160
+9% +$7.96M
NAVI icon
213
Navient
NAVI
$819M
$95.7M 0.09%
5,256,184
+12,158
+0.2% +$238K
XEC
214
DELISTED
CIMAREX ENERGY CO
XEC
$95M 0.09%
861,459
-557,892
-39% -$66.7M
PVH icon
215
PVH
PVH
$4.07B
$95M 0.09%
824,687
-585,354
-42% -$63.5M
EXC icon
216
Exelon
EXC
$48.1B
$94.9M 0.09%
4,233,997
-1,179,477
-22% -$28.3M
NCLH icon
217
Norwegian Cruise Line
NCLH
$9.53B
$94.6M 0.09%
1,687,902
-59,871
-3% -$3.22M
MJN
218
DELISTED
Mead Johnson Nutrition Company
MJN
$94.6M 0.09%
1,048,245
-3,246,021
-76% -$313M
COF icon
219
Capital One
COF
$128B
$93.9M 0.09%
1,067,042
+14,302
+1% +$1.2M
LNT icon
220
Alliant Energy
LNT
$18.6B
$93.6M 0.09%
3,243,122
-198,172
-6% -$6.01M
DYN
221
DELISTED
Dynegy, Inc.
DYN
$92.6M 0.08%
3,164,744
+56,448
+2% +$1.83M
ET icon
222
Energy Transfer Partners
ET
$69.5B
$92.3M 0.08%
2,875,722
+42,196
+1% +$1.41M
XRX icon
223
Xerox
XRX
$345M
$90.9M 0.08%
3,243,434
+11,722
+0.4% +$362K
TGE
224
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$90.5M 0.08%
+2,814,118
New +$89.6M
ARG
225
DELISTED
Airgas Inc
ARG
$88.7M 0.08%
838,464
-257,254
-23% -$26.9M

Similar funds

Jennison Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
  • Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
  • Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
  • Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
  • Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
  • Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
  • Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.

Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.